{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:46:56Z","timestamp":1769197616942,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.waojou.2020.100490","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T23:52:11Z","timestamp":1608335531000},"page":"100490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care"],"prefix":"10.1016","volume":"13","author":[{"given":"Hilda J.I.","family":"De Jong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaco","family":"Voorham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenis K.","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Wahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dermot","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria A.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth B.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-9992","authenticated-orcid":false,"given":"David B.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2020.100490_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13601-017-0153-z","article-title":"Multi-morbidities of allergic rhinitis in adults: European academy of allergy and clinical immunology task Force report","volume":"7","author":"Cingi","year":"2017","journal-title":"Clin Transl Allergy"},{"issue":"8","key":"10.1016\/j.waojou.2020.100490_bib2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1398-9995.2003.00105.x","article-title":"Links between rhinitis and asthma","volume":"58","author":"Bousquet","year":"2003","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2020.100490_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4104\/pcrj.2012.00035","article-title":"Poor asthma control?--then look up the nose. The importance of co-morbid rhinitis in patients with asthma","volume":"21","author":"Scadding","year":"2012","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.waojou.2020.100490_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40733-015-0008-0","article-title":"Allergic rhinitis: the \u201cGhost Diagnosis\u201d in patients with asthma","volume":"1","author":"Egan","year":"2015","journal-title":"Asthma Res Pract"},{"issue":"2 Suppl","key":"10.1016\/j.waojou.2020.100490_bib5","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1378\/chest.111.2_Supplement.11S","article-title":"One airway, one disease","volume":"111","author":"Grossman","year":"1997","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.waojou.2020.100490_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2500\/ajra.2012.26.3762","article-title":"The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis","volume":"26","author":"Feng","year":"2012","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2020.100490_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaci.2003.10.010","article-title":"Association between asthma and rhinitis according to atopic sensitization in a population-based study","volume":"113","author":"Leynaert","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 86","key":"10.1016\/j.waojou.2020.100490_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the world health organization, GA(2)len and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2020.100490_bib9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4104\/pcrj.2009.00037","article-title":"The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control","volume":"18","author":"Clatworthy","year":"2009","journal-title":"Prim Care Respir J"},{"issue":"4","key":"10.1016\/j.waojou.2020.100490_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.alit.2019.04.008","article-title":"Asthma exacerbations in patients with asthma and rhinitis: factors associated with asthma exacerbation and its effect on QOL in patients with asthma and rhinitis","volume":"68","author":"Ohta","year":"2019","journal-title":"Allergol Int"},{"issue":"6","key":"10.1016\/j.waojou.2020.100490_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/02770903.2017.1353611","article-title":"Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia","volume":"55","author":"Bosnic-Anticevich","year":"2018","journal-title":"J\u00a0Asthma"},{"issue":"3","key":"10.1016\/j.waojou.2020.100490_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1398-9995.2007.01584.x","article-title":"Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study","volume":"63","author":"Magnan","year":"2008","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2020.100490_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1542\/peds.2004-0067","article-title":"Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis","volume":"115","author":"Thomas","year":"2005","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.waojou.2020.100490_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2222.2005.02182.x","article-title":"Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults","volume":"35","author":"Price","year":"2005","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2020.100490_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcrj.2005.11.002","article-title":"International primary care respiratory group (IPCRG) guidelines: management of allergic rhinitis","volume":"15","author":"Price","year":"2006","journal-title":"Prim Care Respir J"},{"issue":"6","key":"10.1016\/j.waojou.2020.100490_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1398-9995.2006.01007.x","article-title":"Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial","volume":"61","author":"Price","year":"2006","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2020.100490_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2003.11.034","article-title":"Rhinitis therapy and the prevention of hospital care for asthma: a case-control study","volume":"113","author":"Corren","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2020.100490_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1067\/mai.2002.120554","article-title":"Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits","volume":"109","author":"Crystal-Peters","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 62","key":"10.1016\/j.waojou.2020.100490_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1398-9995.2000.055suppl62012.x","article-title":"A\u00a0comparison of the clinical efficacy and safety of intranasal fluticasone propionate and antihistamines in the treatment of rhinitis","volume":"55","author":"Foresi","year":"2000","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2020.100490_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4104\/pcrj.2010.00040","article-title":"Observational study comparing intranasal mometasone furoate with oral antihistamines for rhinitis and asthma","volume":"19","author":"Price","year":"2010","journal-title":"Prim Care Respir J"},{"issue":"5","key":"10.1016\/j.waojou.2020.100490_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/all.12124","article-title":"Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis","volume":"68","author":"Lohia","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100490_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13601-015-0083-6","article-title":"The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey","volume":"5","author":"Price","year":"2015","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2020.100490_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000351404","article-title":"Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis","volume":"161","author":"Meltzer","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100490_bib24","unstructured":"Dymista Summary of Product Characteristics. Electronic Medicines Compendium (UK). https:\/\/www.medicines.org.uk\/emc\/product\/9450."},{"issue":"7","key":"10.1016\/j.waojou.2020.100490_bib25","first-page":"495","article-title":"A\u00a0new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis","volume":"23","author":"Price","year":"2013","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2020.100490_bib26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12903","article-title":"MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children","volume":"71","author":"Berger","year":"2016","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2020.100490_bib27","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.jaip.2018.01.031","article-title":"Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber","volume":"6","author":"Bousquet","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.waojou.2020.100490_bib28","first-page":"1426","article-title":"A\u00a0comparison of health care resource utilization and costs for patients with allergic rhinitis on single-product or free-combination therapy of intranasal steroids and intranasal antihistamines","volume":"22","author":"Harrow","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.waojou.2020.100490_bib29","doi-asserted-by":"crossref","first-page":"920el","DOI":"10.1016\/j.jaci.2010.10.058","article-title":"How representative are clinical study patients with allergic rhinitis in primary care?","volume":"127","author":"Costa","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.waojou.2020.100490_bib30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1586\/1744666X.2015.1081814","article-title":"Current controversies and challenges in allergic rhinitis management","volume":"11","author":"Price","year":"2015","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100490_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13601-019-0255-x","article-title":"Quality standards in respiratory real-life effectiveness research: the REal life EVidence AssessmeNt tool (RELEVANT): report from the respiratory effectiveness group-European academy of allergy and clinical immunology task Force","volume":"9","author":"Roche","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.waojou.2020.100490_bib32","unstructured":"Optimum Patient Care Research Database. https:\/\/opcrd.co.uk\/."},{"key":"10.1016\/j.waojou.2020.100490_bib33","unstructured":"Respiratory Effectiveness Group. ADEPT Committee. https:\/\/www.regresearchnetwork.org\/adept-committee\/."},{"key":"10.1016\/j.waojou.2020.100490_bib34","unstructured":"European Network of Centres for Pharmacology and Pharmacovigilance. http:\/\/www.encepp.eu\/."},{"key":"10.1016\/j.waojou.2020.100490_bib35","first-page":"29","article-title":"Performance of database-derived severe exacerbations and asthma control measures in asthma: responsiveness and predictive utility in a UK primary care database with linked questionnaire data","volume":"9","author":"Colice","year":"2018","journal-title":"Pragmat Obs Res"},{"issue":"1","key":"10.1016\/j.waojou.2020.100490_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.waojou.2020.100490_bib37","unstructured":"GINA Pocket Guide for Asthma Managment & Prevention. Published online 2018. https:\/\/ginasthma.org\/wp-content\/uploads\/2018\/03\/wms-GINA-main-pocket-guide_2018-v1.0.pdf."},{"key":"10.1016\/j.waojou.2020.100490_bib38","series-title":"REG Endpoint Validation: Do Database Asthma Control Measures Predict Future Risk?","author":"Brusselle","year":"2014"},{"key":"10.1016\/j.waojou.2020.100490_bib39","series-title":"The Global Asthma Report","year":"2018"},{"key":"10.1016\/j.waojou.2020.100490_bib40","unstructured":"Global Atlas of Allergic Rhinitis & Chronic Rhinosinusitis. European Academy of Allergy & Clinical Immunology. http:\/\/webcast.eaaci.cyim.com\/mediatheque\/media.aspx?mediaId=60232&channel=8518."},{"issue":"Suppl 85","key":"10.1016\/j.waojou.2020.100490_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1398-9995.2007.01549.x","article-title":"A\u00a0survey of the burden of allergic rhinitis in Europe","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.waojou.2020.100490_bib42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1398-9995.2005.00819.x","article-title":"Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma","volume":"60","author":"Dahl","year":"2005","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2020.100490_bib43","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/S0012-3692(15)52583-X","article-title":"Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control","volume":"128","author":"Nathan","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.waojou.2020.100490_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1398-9995.2009.02187.x","article-title":"Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis","volume":"65","author":"Nair","year":"2010","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2020.100490_bib45","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of severe asthma worldwide: data from the international severe asthma registry (ISAR)","volume":"157","author":"Wang","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.waojou.2020.100490_bib46","series-title":"Protocol to identify potential severe asthma in UK primary care","first-page":"18381","author":"Heatley","year":"2019"},{"key":"10.1016\/j.waojou.2020.100490_bib47","unstructured":"Aasbjerg, K., Munzel, U., Wick-Urban, B., Marschall, K., Torp-Pedersen, C., Backer, V. Correlation between treatment for allergic rhinitis and the use of asthma medication. Allergy. 73:575."},{"key":"10.1016\/j.waojou.2020.100490_bib48","series-title":"Effectiveness of MP-AzeFlu in Patietns with Different Allergic Rhinitis Phenotypes: A German, Multicentre, Prospective Study","author":"Klimek","year":"2019"},{"key":"10.1016\/j.waojou.2020.100490_bib49","series-title":"Asthma-releated outcomes in a real world study of MP-AzeFlu to treat allergic rhinitis","first-page":"TP0795","author":"Klimek","year":"2019"},{"issue":"3","key":"10.1016\/j.waojou.2020.100490_bib50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mai.2001.113046","article-title":"Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways","volume":"107","author":"Braunstahl","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100490_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13223-018-0311-4","article-title":"Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers","volume":"14","author":"Roca-Ferrer","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100490_bib52","series-title":"Overadditive effects of MP-AzeFlu\u2217 on antiinflammatory genes and inhibition of proinflammatory mediators compared to fluticasone propionate and azelastine in sinonasal fibroblasts","author":"Pujols","year":"2017"},{"issue":"5","key":"10.1016\/j.waojou.2020.100490_bib53","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/all.13349","article-title":"MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis","volume":"73","author":"Kortekaas Krohn","year":"2018","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2020.100490_bib54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1945892418768590","article-title":"Blood eosinophil and basophil values before and after surgery for eosinophilic-type sinonasal polyps","volume":"32","author":"Brescia","year":"2018","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.waojou.2020.100490_bib55","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/npjpcrm.2016.33","article-title":"UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study","volume":"26","author":"Price","year":"2016","journal-title":"NPJ Prim Care Respir Med"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:42:46Z","timestamp":1761849766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455120303938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1939455120303938"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100490","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100490"}}